Trials In Focus

Inside Stories – Asian trial growth creates hurdles Despite rapid growth in clinical trial activity across Asia, sponsors and CROs need to take care in managing unfamiliar environments says the CEO of Australian-based CRO, Novotech. Alek Safarian told the 46th annual meeting of the Drug Information Association (DIA) in Washington DC last week that regulatory [...]

Novotech CEO to speak on Clinical Projects – Faster and Smarter it’s All in the Planning at the 46th DIA Annual Meeting June 13-17 in Washington, DC

Washington, DC, June 13, 2010 – Leading Australian contract clinical research company Novotech announced today that Novotech CEO Alek Safarian will be sharing the company’s Asia Region expertise and experience at DIA 2010 to be held in Washington, DC. Safarian will speak on “Global Study Experiences: Lessons from Observing Regional Variations” which is part of [...]

Novotech alerts Pharma and Biotechs at DIA 2007 to Australias new R&D tax break that applies to clinical trials

New Tax break comes into effect July 1, 2007 Atlanta, GA – July 1, 2007 — Novotech, the largest Australian owned contract research organization (CRO) with offices on the US east and west coasts, announced on the eve of DIA 2007 that the new tax breaks for research in Australia, which includes clinical trials, starts [...]

Novotech says Australia ideally placed to become Bioequivalence trials hub

Sydney, Australia, May 15, 2007 — Novotech, the largest independent Australian owned contract research organization (CRO) with expertise in TGA/EMEA/FDA registration said today Australia should aggressively market its bioequivalence trials capabilities overseas and take a large share of the multi-billion dollar sector. Already more than 70% of Novotech’s bioequivalence work comes from offshore, according to [...]

Updated checklist for CRO partnering and trials selection in Australasian region announced at BIO 2007

May 8, 2007 – Boston, MA — Novotech, the largest Australian owned contract research organization (CRO) with offices on the US east and west coasts, has released its updated “Clinical Trials Checklist” for CROs, biotech, pharma and even VCs, to assist in the often challenging task of selecting a clinical trials partner in the Australasian [...]